Filter your results
- 2
- 1
- 3
- 3
- 1
- 2
- 3
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Achieving SVR Does Not Prevent From Fibrosis Progession In Patients With FCH Results From A Large French Prospective Multicentric ANRS CO23 Cupilt CohortHepatology, 2017, 66, pp.872A-872A
Journal articles
hal-01769633v1
|
|||
Achieving SVR Does Not Prevent From Fibrosis Progression In Patients With FCH: Results From A Large French Prospective Multicentric ANRS CO23 Cupilt CohortHepatology, 2017, 66, pp.872A-872A
Journal articles
hal-01684629v1
|
|||
|
HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantationClinics and Research in Hepatology and Gastroenterology, 2022, 46 (9), pp.102024. ⟨10.1016/j.clinre.2022.102024⟩
Journal articles
hal-03799246v1
|